Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10048882HBVENSG00000196839.14protein_codingADANoNo100A0A0S2Z381
F5GWI4
P00813
TVIS30003290HIVENSG00000196839.14protein_codingADANoNo100A0A0S2Z381
F5GWI4
P00813
TVIS30007998HIVENSG00000196839.14protein_codingADANoNo100A0A0S2Z381
F5GWI4
P00813
TVIS30053729HIVENSG00000196839.14protein_codingADANoNo100A0A0S2Z381
F5GWI4
P00813
TVIS20067170HPVENSG00000196839.14protein_codingADANoNo100A0A0S2Z381
F5GWI4
P00813
TVIS44018262HTLV-1ENSG00000196839.14protein_codingADANoNo100A0A0S2Z381
F5GWI4
P00813
TCGA Plot Options
Drug Information
GeneADA
DrugBank IDDB03000
Drug NameS-9-(2-hydroxypropyl)adenine
Target IDBE0002214
UniProt IDP00813
Regulation Typeinhibitor
PubMed IDs17839440; 33997363
CitationsDE Clercq E, Descamps J, DE Somer P, Holyacute A: (S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity. Science. 1978 May 5;200(4341):563-5. doi: 10.1126/science.200.4341.563.@@Sharmila Tagore S, Swaminathan J, Manikandan D, Gomathi S, Sabarinathan N, Ramalingam M, Sethuraman V: Crystallographic investigation, Hirshfeld surface analysis, NLO characterization and experimental spectral (UV and NMR) studies with DFT probe on(R)-9-(2-hydroxy propyl)adenine. Heliyon. 2021 Apr 29;7(4):e06593. doi: 10.1016/j.heliyon.2021.e06593. eCollection 2021 Apr.
GroupsExperimental
Direct Classification6-aminopurines
SMILES[H][C@@](C)(O)CN1C=NC2=C(N)N=CN=C12
Pathways
PharmGKB
ChEMBL